Quarter
Charts

LAM RESEARCH CORPORATION

LRCX

CIK 0000707549 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-29) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$5.84B
↑+23.8% +$1.12Bvs FY2025 (Q1)
Operating Income
$2.05B
↑+31.1% +$485Mvs FY2025 (Q1)
Net Income
$1.83B
↑+37.2% +$495Mvs FY2025 (Q1)
Gross Profit
$2.91B
↑+25.8% +$597Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
86/100
  • Profitability
    100ROIC 38.1% (10% = solid, 20%+ = moat)
  • Liquidity
    86Current Ratio 2.21 (above 1.5 = solid)
  • Leverage
    77D/E 0.45 (under 0.5 = conservative)
  • Efficiency
    55Asset Turnover 0.92x (1.0+ = capital-efficient)
  • Growth
    96Revenue YoY +23.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 35.0% · trend +3.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project LRCX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 28.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$139.97
Total enterprise IV
$180.58B
Diluted shares
1.29B
Terminal PV
$140.21B (78% of total)
Year-5 FCF
$16.52B
YearProjected FCFDiscounted PV
+1$6.77B$6.15B
+2$8.46B$6.99B
+3$10.57B$7.94B
+4$13.22B$9.03B
+5$16.52B$10.26B
Terminal$225.81B$140.21B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$950M
investment in PP&E
Dividends paid (TTM)
$1.24B
cash returned to holders
Stock buybacks (TTM)
$4.90B
share count reduction
Stock-based comp (TTM)
$377M
non-cash dilution

Balance sheet · 2026-03-29

latest filed snapshot
Total assets
$20.79B
everything owned
Total liabilities
$10.21B
everything owed
Stockholders' equity
$10.58B
shareholder claim
Net debt
$-282M
Net cash position ($282M)

Recent performance · 68 quarters

Revenue↑+23.8% +$1.12B
$5.84B
Net Income↑+37.2% +$495M
$1.83B
Free Cash Flow↓-20.7% -$211M
$810M
Operating Margin↑+2.0pts
35.0%

Drill down

LRCX Sankey

See LAM RESEARCH CORPORATION's revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

LRCX Charts

68 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

LRCX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics